Try Out Investing Whisperer for only $5.00

Get my #1 Junior Biotech Play — For Just $5

Things have gotten really interesting for my top biotech.

The long-awaited Phase 3 readout on its cancer drug is expected to come out very soon.

What makes this cancer drug different from all the others?

It’s all about two things:

1) Its delivery vehicle, which is designed to deliver a payload to the site of cancer cells, while limiting exposure to healthy cells.

2) The payload… which effectively kills the bad (targeted) cells.

Their drug has 100% response rate so far, and FDA approval is expected this year, with product launch in 2024.

If the near-term results prove out, the stock will fly… and the upside is enormous.

That’s because the Market will view the company as a wider play on ALL cancer trials.

In other words, it will reward the company’s vast potential.

The stock has climbed as high as 29% since I recommended it a month ago to Investing Whisperer members.

And the stock — trading for just a few dollars a share — just hit new 52-week highs!

It could become our biggest win of 2023… and possibly a ten-bagger from here.

So today I’m offering my free blog readers the opportunity to get my Full Research on this potentially blockbuster biotech company…

For only $5.

Simply fill out the brief fields below for access and full membership right away.

As a new member, you’ll get:

  • Access to the Full Report on my #1 biotech play — along with a second very promising biotech play — highlighted at the top of the Members Center
  • All paid subscriber Investing Whisperer emails, alerts, and special reports
  • Full access to the Current Portfolio, and Archive of all past paid subscriber Whispers.

You’ll pay only $5 for the first month, then U.S. $99 a month after that (you can cancel at any time).

Get started below!

Portfolio Wins of Note:  Capricor Therapeutics (CAPR-NASD): 721% gain in 10 weeks | Green Plains Renewables (GPRE-NASD): 500%+ gain in 18 months | Aston Martin (ARGGY-OTC): 55% gain in < 5 months | Viemed (VMD-TSX): $2.50 to $10 in 8 months | SONA Nanotech (SONA-CSE): 109% gain in 2 weeks | Viper Energy (VNOM-NASD): $15.50 to $40 in 12 months | GeoPark Energy (GPRK-NYSE): $10 to $20 in 3 months  | Resolute Energy (REN-NYSE): $5 to $48 in 7 months | Pacific Ethanol (PEIX-NYSE): $3 to $23 in 9 months | AEHR Test Systems (AEHR-NASD): 70% gain in < 5 months | Atlas Engineering Products (AEP-TSXv / AEPUF-OTC): 67% in 14 months